Provenance Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Provenance Wealth Advisors's AMGN Position: Q2 2026 in Review
Provenance Wealth Advisors increased its Amgen (AMGN) stake by 3.8% in Q2 2026, buying an estimated $6.5K and bringing the position to 519 shares worth $188K. The position accounts for 0.02% of the portfolio, ranked #142.
Provenance Wealth Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $903K in Q4 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Provenance Wealth Advisors held 519 shares of Amgen worth $188K as of Q2 2026.
- Provenance Wealth Advisors bought 19 Amgen shares in Q2 2026, an estimated $6.5K.
- Amgen made up 0.02% of Provenance Wealth Advisors's portfolio in Q2 2026, its #142 holding.
- Provenance Wealth Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
- Provenance Wealth Advisors's Amgen position peaked at $903K in Q4 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.